175 related articles for article (PubMed ID: 22149578)
1. Crofelemer for the treatment of secretory diarrhea.
Cottreau J; Tucker A; Crutchley R; Garey KW
Expert Rev Gastroenterol Hepatol; 2012 Feb; 6(1):17-23. PubMed ID: 22149578
[TBL] [Abstract][Full Text] [Related]
2. Crofelemer, a novel antisecretory agent approved for the treatment of HIV-associated diarrhea.
Yeo QM; Crutchley R; Cottreau J; Tucker A; Garey KW
Drugs Today (Barc); 2013 Apr; 49(4):239-52. PubMed ID: 23616951
[TBL] [Abstract][Full Text] [Related]
3. Crofelemer, a novel agent for treatment of secretory diarrhea.
Crutchley RD; Miller J; Garey KW
Ann Pharmacother; 2010 May; 44(5):878-84. PubMed ID: 20388859
[TBL] [Abstract][Full Text] [Related]
4. Crofelemer: In HIV Associated Diarrhea and Secretory Diarrhea - A Patent Perspective.
Biswal S
Recent Pat Antiinfect Drug Discov; 2014; 9(2):136-43. PubMed ID: 25851117
[TBL] [Abstract][Full Text] [Related]
5. Crofelemer, an antisecretory antidiarrheal proanthocyanidin oligomer extracted from Croton lechleri, targets two distinct intestinal chloride channels.
Tradtrantip L; Namkung W; Verkman AS
Mol Pharmacol; 2010 Jan; 77(1):69-78. PubMed ID: 19808995
[TBL] [Abstract][Full Text] [Related]
6. Crofelemer: a review of its use in the management of non-infectious diarrhoea in adult patients with HIV/AIDS on antiretroviral therapy.
Frampton JE
Drugs; 2013 Jul; 73(10):1121-9. PubMed ID: 23807722
[TBL] [Abstract][Full Text] [Related]
7. Crofelemer, a novel agent for treatment of non-infectious diarrhea in HIV-infected persons.
Chordia P; MacArthur RD
Expert Rev Gastroenterol Hepatol; 2013 Sep; 7(7):591-600. PubMed ID: 24070150
[TBL] [Abstract][Full Text] [Related]
8. Crofelemer for the symptomatic relief of non-infectious diarrhea in adult patients with HIV/AIDS on anti-retroviral therapy.
Castro JG; Chin-Beckford N
Expert Rev Clin Pharmacol; 2015; 8(6):683-90. PubMed ID: 26517110
[TBL] [Abstract][Full Text] [Related]
9. HALT-D: A Phase II Evaluation of Crofelemer for the Prevention and Prophylaxis of Diarrhea in Patients With Breast Cancer on Pertuzumab-Based Regimens.
Gao JJ; Tan M; Pohlmann PR; Swain SM
Clin Breast Cancer; 2017 Feb; 17(1):76-78. PubMed ID: 27692565
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of crofelemer for noninfectious diarrhea in HIV-seropositive individuals (ADVENT trial): a randomized, double-blind, placebo-controlled, two-stage study.
Macarthur RD; Hawkins TN; Brown SJ; Lamarca A; Clay PG; Barrett AC; Bortey E; Paterson C; Golden PL; Forbes WP
HIV Clin Trials; 2013; 14(6):261-73. PubMed ID: 24334179
[TBL] [Abstract][Full Text] [Related]
11. Randomized Clinical Trial: Crofelemer Treatment in Women With Diarrhea-Predominant Irritable Bowel Syndrome.
Nee J; Salley K; Ludwig AG; Sommers T; Ballou S; Takazawa E; Duehren S; Singh P; Iturrino J; Katon J; Lee HN; Rangan V; Lembo AJ
Clin Transl Gastroenterol; 2019 Dec; 10(12):e00110. PubMed ID: 31800542
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of crofelemer in the treatment of diarrhea-predominant irritable bowel syndrome patients.
Mangel AW; Chaturvedi P
Digestion; 2008; 78(4):180-6. PubMed ID: 19092244
[TBL] [Abstract][Full Text] [Related]
13. CFTR inhibitors for treating diarrheal disease.
Thiagarajah JR; Verkman AS
Clin Pharmacol Ther; 2012 Sep; 92(3):287-90. PubMed ID: 22850599
[TBL] [Abstract][Full Text] [Related]
14. Crofelemer for the treatment of chronic diarrhea in patients living with HIV/AIDS.
Patel TS; Crutchley RD; Tucker AM; Cottreau J; Garey KW
HIV AIDS (Auckl); 2013; 5():153-62. PubMed ID: 23888120
[TBL] [Abstract][Full Text] [Related]
15. Antidiarrheal activity of cashew GUM, a complex heteropolysaccharide extracted from exudate of Anacardium occidentale L. in rodents.
Araújo TS; Costa DS; Sousa NA; Souza LK; de Araújo S; Oliveira AP; Sousa FB; Silva DA; Barbosa AL; Leite JR; Medeiros JV
J Ethnopharmacol; 2015 Nov; 174():299-307. PubMed ID: 26297843
[TBL] [Abstract][Full Text] [Related]
16. A novel extract SB-300 from the stem bark latex of Croton lechleri inhibits CFTR-mediated chloride secretion in human colonic epithelial cells.
Fischer H; Machen TE; Widdicombe JH; Carlson TJ; King SR; Chow JW; Illek B
J Ethnopharmacol; 2004 Aug; 93(2-3):351-7. PubMed ID: 15234776
[TBL] [Abstract][Full Text] [Related]
17. Crofelemer (Fulyzaq) for antiretroviral-induced diarrhea.
Med Lett Drugs Ther; 2013 Jul; 55(1421):59-60. PubMed ID: 23863919
[No Abstract] [Full Text] [Related]
18. Discovery and development of antisecretory drugs for treating diarrheal diseases.
Thiagarajah JR; Ko EA; Tradtrantip L; Donowitz M; Verkman AS
Clin Gastroenterol Hepatol; 2014 Feb; 12(2):204-9. PubMed ID: 24316107
[TBL] [Abstract][Full Text] [Related]
19. Developing novel antisecretory drugs to treat infectious diarrhea.
de Hostos EL; Choy RK; Nguyen T
Future Med Chem; 2011 Aug; 3(10):1317-25. PubMed ID: 21859305
[TBL] [Abstract][Full Text] [Related]
20. Dacomitinib-induced diarrhea: Targeting chloride secretion with crofelemer.
Van Sebille YZA; Gibson RJ; Wardill HR; Ball IA; Keefe DMK; Bowen JM
Int J Cancer; 2018 Jan; 142(2):369-380. PubMed ID: 28921512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
